Abstract: The present invention provides compounds useful as inhibitors of ATP citrate lyase (ACLY), compositions thereof, and methods of using the same.

Abstract: The present invention provides compounds useful as inhibitors of ATP citrate lyase (ACLY), compositions thereof, and methods of using the same.

Abstract: The present invention provides methods of treating, stabilizing or lessening the severity or progression of a non-alcoholic fatty liver disease using an ACC inhibitor alone or with one or more additional therapeutic agents.

Abstract: The present invention provides compounds useful as inhibitors of Acetyl CoA Carboxylase (ACC), compositions thereof, and methods of using the same.

Abstract: The present invention provides methods of treating, stabilizing or lessening the severity or progression of a non-alcoholic fatty liver disease using an ACC inhibitor alone or with one or more additional therapeutic agents.

Abstract: A method of forming a functionalized polymer, the method comprising reacting a living polymer with a compound defined by the formula where R5 includes a monovalent organic group, R6 independently includes a monovalent organic group, each R7 independently includes hydrogen or a monovalent organic group, each R8 independently includes hydrogen or monovalent organic group, R9 includes a monovalent organic group, M is silicon or tin, and x includes an integer from about 2 to about 10, where R5 and R6 may optionally each independently be alkoxy groups, and where R7, R8, and R9 are non-Zerewitinoff organic groups.

Abstract: A method of forming a functionalized polymer, the method comprising reacting a living polymer with a compound defined by the formula where R5 includes a monovalent organic group, R6 independently includes a monovalent organic group, each R7 independently includes hydrogen or a monovalent organic group, each R8 independently includes hydrogen or monovalent organic group, R9 includes a monovalent organic group, M is silicon or tin, and x includes an integer from about 2 to about 10, where R5 and R6 may optionally each independently be alkoxy groups, and where R7, R8, and R9 are non-Zerewitinoff organic groups.

Abstract: A method of forming a functionalized polymer, the method comprising reacting a living polymer with a compound defined by the formula where R5 includes a monovalent organic group, R6 independently includes a monovalent organic group, each R7 independently includes hydrogen or a monovalent organic group, each R8 independently includes hydrogen or monovalent organic group, R9 includes a monovalent organic group, M is silicon or tin, and x includes an integer from about 2 to about 10, where R5 and R6 may optionally each independently be alkoxy groups, and where R7, R8, and R9 are non-Zerewitinoff organic groups.

Abstract: Acetyl Coenzyme A Carboxylase inhibitors, pharmaceutical compositions containing such compounds and the use of such compounds to treat for example, Metabolic Syndrome including atherosclerosis, diabetes and obesity.

Abstract: Acetyl Coenzyme A Carboxylase inhibitors, pharmaceutical compositions containing such compounds and the use of such compounds to treat for example, Metabolic Syndrome including atherosclerosis, diabetes and obesity.

Abstract: A polymerization process comprising the steps of admixing a halogen-containing compound, monomer, and a cobalt complex.

Abstract: Disclosed are cyclic phosphate esters of fumarate—or maleic acids suitable for use as a comonomer, capable of being copolymerized with a monovinylidene aromatic compounds to impart flame resistant properties to the resultant copolymers.

Abstract: Disclosed are cyclic phosphate esters of fumarate- or maleic acids suitable for use as a comonomer, capable of being copolymerized with a monovinylidene aromatic compounds to impart flame resistant properties to the resultant copolymers.

Abstract: A method for making a polymer comprising the step of synthesizing a polymer by employing a chain transfer agent having the formula (II) where X and Y are independently selected from oxygen, sulfur, and fully-substituted nitrogen where R1 and R2 are independently selected from hydrogen, halogen, or an organic group, with the proviso that at least one of R1 or R2 be hydrogen or halogen, R3 is an organic group R4 and R5 are independently selected organic groups, with the proviso that R3 is not hydrogen.

Abstract: Disclosed are cyclic phosphate esters of fumarate- or maleic acids suitable for use as a comonomer, capable of being copolymerized with a monovinylidene aromatic compounds to impart flame resistant properties to the resultant copolymers.

Abstract: A method for making a polymer comprising the step of synthesizing a polymer by employing a chain transfer agent having the formula (II) 1

Abstract: The present invention is directed toward anionic polymerization initiators which are soluble in acyclic alkane solvents. The initiators include a solubilized lithio amine having the general formula (A)Li(SOL).sub.y. SOL is a solubilizing component and A is an alkyl, dialkyl or cycloalkyl amine radical or a cyclic amine and y is from about 1 to 4. The cyclic amine has an alkylene, oxy- or amino-alkylene group having from about 3 to about 16 methylene groups. The invention is also directed toward polymers and other products made using the initiator, and methods therefor. Further, the invention contemplates a polymer, a polymer composition and products therefrom, which include a functional group from the reaction product of an amine and an organolithium compound. The resulting polymers may be terminated with a terminating, coupling or linking agent, which may provide the polymer with a multifunctionality.

Abstract: This invention describes chemical modifications of hydrogenated polymers, particularly thermoplastic elastomers, e.g., Kraton.RTM. G, to increase the chemical resistance thereof. The number of residual reactive unsaturated diene-based mid-blocks were reduced through a post-hydrogenation reaction with an alkyl phenyl ether, e.g., anisole. The anisolated thermoplastic elastomer was then further reacted with benzenesulfonylation and nitration reactions to produce even more useful derivatives thereof.

Abstract: A curable composition which comprises:(a) an anhydride-functional polymer obtained by polymerizing under free radical addition polymerization conditions, a monomer mixture comprising:(i) 20 to 75 weight percent of an alkenyl succinic anhydride having the structure: ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are each independently hydrogen or alkyl or substituted alkyl of 1 to about 30 carbons; and(ii) 25 to 80 weight percent of at least one (meth)acrylic monomer copolymerizable with the alkenyl succinic anhydride; and, optionally,(iii) 0 to 75 weight percent of at least one unsaturated monomer, other than a (meth)acrylic monomer, which is copolymerizable with the anhydride and the (meth)acrylic monomer; and(b) a compound having an average of at least two functional groups per molecule which are reactive with anhydride groups.

Abstract: A curable composition which comprises:(a) an anhydride-functional polymer obtained by polymerizing under free radical addition polymerization conditions, a monomer mixture comprising:(i) 20 to 75 weight percent of an alkenyl succinic anhydride having the structure: ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are each independently hydrogen or alkyl or substituted alkyl of 1 to about 30 carbons; and(ii) 25 to 80 weight percent of at least one (meth)acrylic monomer copolymerizable with the alkenyl succinic anhydride; and, optionally,(iii) 0 to 75 weight percent of at least one unsaturated monomer, other than a (meth)acrylic-monomer, which is copolymerizable with the anhydride and the (meth)acrylic monomer; and(b) a compound having an average of at least two functional groups per molecule which are reactive with anhydride groups.